21 insiders have filed at EW since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Mussallem Michael A | Director | 4.04M | 0.696% | 25 sells $25.9M | |
| Ullem Scott B. | Cvp, Chief Financial Officer | 306.0k | 0.053% | 25 sells $13.7M | |
| Wood Larry L | Global President Tavr & Surg | 207.0k | 0.036% | 12 sells $6.8M | |
| Zovighian Bernard J | CEO | 202.5k | 0.035% | 1 buys $50k | 9 sells $6.8M |
| Lemercier Jean-Luc M | Cvp, Emeacla And Japac | 184.7k | 0.032% | 5 sells $3.9M | |
| Bobo Donald E JR | Cvp,strategy/Corp Development | 181.9k | 0.031% | 35 sells $17.8M | |
| Szyman Catherine M. | Cvp, Critical Care | 81.3k | 0.014% | 6 sells $5.6M | |
| Loranger Steven R | Director | 80.1k | 0.014% | 1 sells $439k | |
| Gallahue Kieran | Director | 79.7k | 0.014% | 1 sells $268k | |
| Valeriani Nicholas J | Director | 79.3k | 0.014% | ||
| Sellers Robert W.A. | SVP, Corporate Controller | 37.5k | <0.01% | 1 sells $1.1M | |
| Lippis Daniel J. | Cvp, Tavr | 33.9k | <0.01% | 16 sells $1.4M | |
| Chopra Daveen | Cvp, Tmtt & Surgical | 32.2k | <0.01% | 12 sells $3.6M | |
| Stone Heisz Leslie | Director | 30.9k | <0.01% | 4 sells $1.5M | |
| Sequeira Ramona | Director | 17.6k | <0.01% | ||
| Markowitz Wayne | Cvp, Japac | 17.6k | <0.01% | 3 sells $113k | |
| Laviolette Paul A | Director | 14.3k | <0.01% | ||
| Bruls Annette | Cvp, Emeacla | 14.2k | <0.01% | ||
| Dahl Andrew M. | SVP, Corporate Controller | 9.1k | <0.01% | ||
| Davis Leslie C. | Director | 6.6k | <0.01% | ||
| Feinberg David T | Director | 5.8k | <0.01% |
Full register at boothcheck.com/insiders/EW. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.